Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Modulating one or more steps within the classical/lectin/alternative pathways that activate the innate immune system’s complement cascade. The complement system consists of a series of plasma proteins that, when activated, enhance the ability of antibodies and phagocytic cells to clear pathogens and damaged cells. It also promotes inflammation and attacks the pathogen's cell membrane. Modulation can occur through targeting specific components or convertases with inhibitors, or through interventions affecting regulatory proteins.
Inhibition/amplification/blockade/removal/regulatory protein targeting within any step from recognition through terminal MAC formation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Activation Pathway Modulation.